Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2176 AL 2190

Modulation of Amyloid-β and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and Donepezil

Alvarez XA, Winston CN, Barlow JW, Sarsoza FM, Alvarez I, Aleixandre M, Linares C, García-Fantini M, Kastberger B, Winter S, Rissman RA.

J Alzheimers Dis. 2022;90(2):705-717. doi: 10.3233/JAD-220575.

Somatic Mutations and Alzheimer's Disease

Downey J, Lam JCK, Li VOK, Gozes I.

J Alzheimers Dis. 2022;90(2):475-493. doi: 10.3233/JAD-220643.

Recent progress in the graphene-based biosensing approaches for the detection of Alzheimer's biomarkers

Rouhi N, Akhgari A, Orouji N, Nezami A, Rahimzadegan M, Kamali H.

J Pharm Biomed Anal. 2023 Jan 5;222:115084. doi: 10.1016/j.jpba.2022.115084. Epub 2022 Sep 28.

High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects

Villain N, Planche V, Levy R.

Rev Neurol (Paris). 2022 Dec;178(10):1011-1030. doi: 10.1016/j.neurol.2022.06.012. Epub 2022 Sep 29.

Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial

Pontecorvo MJ, Lu M, Burnham SC, Schade AE, Dage JL, Shcherbinin S, Collins EC, Sims JR, Mintun MA.

JAMA Neurol. 2022 Dec 1;79(12):1250-1259. doi: 10.1001/jamaneurol.2022.3392.

Metal-organic frameworks: A promising option for the diagnosis and treatment of Alzheimer's disease

Tajahmadi S, Molavi H, Ahmadijokani F, Shamloo A, Shojaei A, Sharifzadeh M, Rezakazemi M, Fatehizadeh A, Aminabhavi TM, Arjmand M.

J Control Release. 2023 Jan;353:1-29. doi: 10.1016/j.jconrel.2022.11.002. Epub 2022 Nov 21.

Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential

Olichney J, Xia J, Church KJ, Moebius HJ.

Neural Plast. 2022 Nov 8;2022:2104880. doi: 10.1155/2022/2104880. eCollection 2022.

Dementia Prevention in Clinical Practice

Niotis K, Akiyoshi K, Carlton C, Isaacson R.

Semin Neurol. 2022 Oct;42(5):525-548. doi: 10.1055/s-0042-1759580. Epub 2022 Nov 28.

Multiparametric Quantitative Imaging Biomarker as a Multivariate Descriptor of Health: A Roadmap

Raunig DL, Pennello GA, Delfino JG, Buckler AJ, Hall TJ, Guimaraes AR, Wang X, Huang EP, Barnhart HX, deSouza N, Obuchowski N.

Acad Radiol. 2023 Feb;30(2):159-182. doi: 10.1016/j.acra.2022.10.026. Epub 2022 Dec 1.

Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study

McDade E, Cummings JL, Dhadda S, Swanson CJ, Reyderman L, Kanekiyo M, Koyama A, Irizarry M, Kramer LD, Bateman RJ.

Alzheimers Res Ther. 2022 Dec 21;14(1):191. doi: 10.1186/s13195-022-01124-2.

Treatment of Alzheimer's disease by combination of acupuncture and Chinese medicine based on pathophysiological mechanism: A review

Liu Z, Guan R, Bu F, Pan L.

Medicine (Baltimore). 2022 Dec 9;101(49):e32218. doi: 10.1097/MD.0000000000032218.

Lepidine B from Lepidium sativum Seeds as Multi-Functional Anti- Alzheimer's Disease Agent: In Vitro and In Silico Studies

Talia S, Benarous K, Lamrani M, Yousfi M.

Curr Comput Aided Drug Des. 2021;17(3):360-377. doi: 10.2174/1573409916666200302120305.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias